EASTERN COOPERATIVE ONCOLOGY GROUP

这项续批申请的具体目标是 为梅奥诊所继续参与东部 合作肿瘤学小组活动旨在更大 对癌症及癌症相关问题的认识 改进的癌症治疗方案的发展与癌症 病人存活率。重要的小组活动继续进行 为了包括改进诊断程序的开发， 新的癌症化疗药物的研究和鉴定 综合治疗和新的治疗方案的价值。 将一如既往地将重点放在直接患者护理上 占主导地位的门诊诊所设置。持续的兴趣和 参加与流行病学研究有关的团体活动， 特定肿瘤的自然历史和生物模式将 尽可能地提供。随着新患者的增加 扩大梅奥医疗业务的资源和 继续NCCTG活动，我们预计我们将 超过了我们之前的协议条目和科学贡献。 我们希望继续参与针对特定疾病的 委员会活动、对新协议设计的评估和 治疗方案和可能的行政角色 任命的，适当的。这个ECOG从属关系和治疗 已经发展起来的计划，为Mayo提供了主要好处，其 调查人员，NCCTG成员，他们的地区性癌症 项目，以及参与其中的一大批癌症患者 在这些研究活动中。

The specific objective of this grant continuation application is to provide for Mayo Clinic's continued participation in the Eastern Cooperative Oncology Group activities directed at a greater understanding of cancer and cancer related problems and the development of improved cancer treatment programs and cancer patient survival. Group activities of major importance continue to include the development of improved diagnostic procedures, the study of new cancer chemotherapy agents, and the identification of the value of combined modality therapy and new treatment regimens. Emphasis as before will be placed on direct patient care in a predominant out patient clinic setting. Continued interest and participation in Group activities relate to epidemiologic studies, natural history, and biologic patterns of specific neoplasms will be provided as possible. With the addition of new patient resources in the expansion of the Mayo medical practice and continuing NCCTG activities we would anticipate that we would exceed our previous protocol entry and scientific contribution. We would hope to continue to participate in disease specific committee activities, the evaluation of new protocol design and treatment regimens and such administrative roles as might be appointed and appropriate. This ECOG affiliation and the treatment programs which have evolved, provide major benefits to Mayo, its investigators, the members of NCCTG, their regional cancer programs, and the large group of cancer patients who are involved in these research activities.